MAPT and early-onset autosomal dominant Alzheimer disease: In vivo markers of neurodegeneration that are sensitive to the range of histopathological features of Aβ, tau, and monoamine pathology in Alzheimer’s disease offer a useful complement to existing non-invasive markers of amyloid and tau across the AD continuum.